Quantum Genomics (QNNTF) Stock Price, News & Analysis
Company Description
Quantum Genomics (OTC Link: QNNTF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $7.0M.
QNNTF stock has declined 97.1% over the past year.
This page provides a comprehensive overview of QNNTF stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Quantum Genomics (QNNTF) stock. Over the past 12 months, the stock has lost 97.1%. At a market capitalization of $7.0M, QNNTF is classified as a micro-cap stock with approximately 69.7M shares outstanding.
Latest News
Quantum Genomics has 10 recent news articles. Key topics include clinical trial, earnings, management. View all QNNTF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
QNNTF Company Profile & Sector Positioning
Quantum Genomics (QNNTF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing QNNTF often look at related companies in the same sector, including Bioxytran Inc (BIXT), Glow Lifetech (GLWLF), Sigyn Therapeutics Inc (SIGY), Pharmala Biotech (MDXXF), and Corgi IP Licensing & Royalties ETF (PTNT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate QNNTF's relative position within its industry.